Your browser doesn't support javascript.
loading
Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins.
Mori, Joakin O; Shafran, Jordan S; Stojanova, Marija; Katz, Mark H; Gignac, Gretchen A; Wisco, Jonathan J; Heaphy, Christopher M; Denis, Gerald V.
Affiliation
  • Mori JO; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Shafran JS; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Stojanova M; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Katz MH; Department of Urology, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Gignac GA; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Wisco JJ; Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Heaphy CM; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
  • Denis GV; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Prostate ; 82(10): 1005-1015, 2022 06.
Article de En | MEDLINE | ID: mdl-35403746

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteurs de surface cellulaire / Tumeurs prostatiques résistantes à la castration / Antagonistes des androgènes / Protéines de tissu nerveux Type d'étude: Prognostic_studies Limites: Humans / Male Langue: En Journal: Prostate Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Récepteurs de surface cellulaire / Tumeurs prostatiques résistantes à la castration / Antagonistes des androgènes / Protéines de tissu nerveux Type d'étude: Prognostic_studies Limites: Humans / Male Langue: En Journal: Prostate Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique